Protagenic Therapeutics (PTIX)
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-li...
- Open
- 0.950
- High
- 1.060
- Low
- 0.950
- Prev. Close
- 1.000
- Volume
- 1.68K
- Turnover
- 1.73K
- Avg Price
- 1.026
- Bid/Ask Ratio
- --
- Amplitude
- 10.99%
- 52wk High
- 4.550
- Volume Ratio
- 2.71
- Turnover Ratio
- 0.10%
News
- Global Report · Aug 25 at 10:12 AM
Amylyx's Big Trial Win, Intapp's AI Push, and HWH's Nasdaq Struggle
- Tip Ranks · Aug 25 at 02:10 AM
Top Executive Quietly Ramps Up Stake in This Under-the-Radar Biotech
- PUBT · Aug 24 at 05:20 PM
Protagenic Therapeutics executive chair Garo H. Armen acquires 20,000 common shares for $13,000
- PUBT · Aug 20 at 12:31 PM
Protagenic gets FDA pre-IND feedback supporting planned Phase 1 trial for PT00114 in generalized anxiety disorder
